5-MTHF (5-methyltetrahydrofolate)

DIETARY_SUPPLEMENT3 trials

Sponsors

IRCCS Azienda Ospedaliero-Universitaria di Bologna, University of British Columbia, Dr. Soetomo General Hospital

Conditions

Clinical TrialsFolateFolate BioavailabilityHyperhomocysteinemiaInflammationMortalityPregnancyPregnant Women

Unknown Phase

5-methyltetrahydrofolate Survival and Inflammation in ESRD Patients

CompletedNCT00626223

IRCCS Azienda Ospedaliero-Universitaria di BolognaHyperhomocysteinemia, Inflammation, Mortality

Start: 1998-01-31End: 2007-07-31Updated: 2021-03-18

PREconception Folic Acid Clinical Efficacy (PREFACE) Trial

Not yet recruitingNCT06641245

University of British ColumbiaClinical Trials, Folate, Folate Bioavailability +1

Start: 2025-01-31End: 2030-01-31Target: 272Updated: 2024-10-21

Comparison of The Effect of 5-MTHF and Folic Acid Supplementation in Increasing Red Blood Cell Folate in Pregnant Women

CompletedNCT06935630

Dr. Soetomo General HospitalPregnant Women

Start: 2025-01-01End: 2026-02-28Updated: 2026-07-06

Related Papers

Comparative Bioavailability of 5-Methyltetrahydrofolate and Folic Acid in Pregnant Women: A Randomized Controlled Trial.

2026-09-09